Servier Group consolidated revenue for the 2022-2023 financial year PAVING THE WAY OF OUR 2030 OBJECTIVES

Servier, an independent international pharmaceutical group, has just published its financial results for the 2022-2023 financial year.

These results was marked by major advances in oncology, confirming the Group’s commitment to developing breakthrough innovations for patients with rare and hard-to-treat cancers.